HLA class II and class I polymorphism in Venezuelan patients with myasthenia gravis. 2004

Mercedes T Fernández-Mestre, and Vivian Vargas, and Silvia Montagnani, and Maritza Cotúa, and Violeta Ogando, and Zulay Layrisse
Centro de Medicina Experimental Miguel Layrisse, Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela.

Oligotyping performed among ethnically mixed Venezuelan patients with myasthenia gravis (MG) and controls has revealed positive associations of HLA class I A*31, B*08, B*39, B*40, C*15, C*17, and class II DRB1*09 and negative associations of DQB1*06 and DQA1*02 with the disease. Sequential removal of human leukocyte antigen B (HLA-B) alleles when relative predispositional effects (RPEs) were looked for demonstrated that B*08 is the allele group with the largest contribution in the overall MG patients followed by B*39 and B*40. Several specificities (A*31, B*08, C*17, DRB1*03, DQA1*05, and DQB1*02) indicated increased frequencies among patients with thymic hyperplasia versus patients without hyperplasia or controls. Tests to identify alleles with the strongest association to MG in our patients detected DRB1*13 and B*38 as possible predisposing secondarily associated alleles in patients with hyperplasia. The associations observed disappear after Bonferoni correction of probability values and have been described in patients of Caucasian and/or Oriental ethnic background. Thus, our results reflect the heterogeneity of our population and of the patients tested and suggest a limited influence of several HLA genes in this heterogeneous disease or that these might be only markers of nearby non-HLA genes responsible for the susceptibility or resistance effect.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D005006 Ethnicity A group of people with a common cultural heritage that sets them apart from others in a variety of social relationships. Ethnic Groups,Nationality,Ethnic Group,Nationalities
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D005802 Genes, MHC Class II Genetic loci in the vertebrate major histocompatibility complex that encode polymorphic products which control the immune response to specific antigens. The genes are found in the HLA-D region in humans and include H-2M, I-A, and I-E loci in mice. Class II Genes,Genes, Class II,Genes, HLA Class II,MHC Class II Genes,Class II Gene,Gene, Class II

Related Publications

Mercedes T Fernández-Mestre, and Vivian Vargas, and Silvia Montagnani, and Maritza Cotúa, and Violeta Ogando, and Zulay Layrisse
June 2009, International journal of immunogenetics,
Mercedes T Fernández-Mestre, and Vivian Vargas, and Silvia Montagnani, and Maritza Cotúa, and Violeta Ogando, and Zulay Layrisse
November 2003, European journal of neurology,
Mercedes T Fernández-Mestre, and Vivian Vargas, and Silvia Montagnani, and Maritza Cotúa, and Violeta Ogando, and Zulay Layrisse
January 2006, Human immunology,
Mercedes T Fernández-Mestre, and Vivian Vargas, and Silvia Montagnani, and Maritza Cotúa, and Violeta Ogando, and Zulay Layrisse
February 1991, Annals of neurology,
Mercedes T Fernández-Mestre, and Vivian Vargas, and Silvia Montagnani, and Maritza Cotúa, and Violeta Ogando, and Zulay Layrisse
January 2013, Clinical neurology and neurosurgery,
Mercedes T Fernández-Mestre, and Vivian Vargas, and Silvia Montagnani, and Maritza Cotúa, and Violeta Ogando, and Zulay Layrisse
June 1997, Human immunology,
Mercedes T Fernández-Mestre, and Vivian Vargas, and Silvia Montagnani, and Maritza Cotúa, and Violeta Ogando, and Zulay Layrisse
January 2021, Journal of neuromuscular diseases,
Mercedes T Fernández-Mestre, and Vivian Vargas, and Silvia Montagnani, and Maritza Cotúa, and Violeta Ogando, and Zulay Layrisse
July 1985, Immunological reviews,
Mercedes T Fernández-Mestre, and Vivian Vargas, and Silvia Montagnani, and Maritza Cotúa, and Violeta Ogando, and Zulay Layrisse
June 2007, Human biology,
Mercedes T Fernández-Mestre, and Vivian Vargas, and Silvia Montagnani, and Maritza Cotúa, and Violeta Ogando, and Zulay Layrisse
February 1991, Tissue antigens,
Copied contents to your clipboard!